resultspreview:lookingfor+$13m ebitda&$54m rev, page-10

I am new to this company. Results to me look not too bad. Revenue is flat, debt is lower, cash flow is good. No growth. In general, it is undervalued. But I don't believe this company is going to broke. Nothing scares me. In Australia, this type of clinical company, under good management,will manage to grow, under incompetent management, will be flat or slightly bad, but revenue is generally stable. This company didn't get broken in 2008 GFC, now its balance sheet is getting better and it needs bit more time to reposition itsself. It is matter of time to get dividend back. It also has the potential of becoming a takeover target once its debt is reduced to minimum.